AstraZeneca makes deal with White House to lower drug prices

AstraZeneca CEO Pascal Soriot shakes hands with President Trump in the Oval Office, as Health and Human Services Secretary Robert F. Kennedy Jr. looks on.

The U.K.-based drugmaker became the second to strike a deal with the Trump administration as part of the president's push to rein in U.S. drug prices.

(Image credit: Andrew Harnik)